118 related articles for article (PubMed ID: 15213703)
1. Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region.
Wang H; Ng K; Hayes D; Gao X; Forster G; Blaha C; Yeomans J
Neuropsychopharmacology; 2004 Dec; 29(12):2126-39. PubMed ID: 15213703
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic activity and behaviour in SOCS2 transgenic mice: Revealing a potential drug target for schizophrenia.
Ratnayake U; Basrai HS; Turnley AM; van den Buuse M
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():247-53. PubMed ID: 25283341
[TBL] [Abstract][Full Text] [Related]
3. Acute food deprivation reverses morphine-induced locomotion deficits in M5 muscarinic receptor knockout mice.
Steidl S; Lee E; Wasserman D; Yeomans JS
Behav Brain Res; 2013 Sep; 252():176-9. PubMed ID: 23742799
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic control of morphine-induced locomotion in rostromedial tegmental nucleus versus ventral tegmental area sites.
Wasserman DI; Wang HG; Rashid AJ; Josselyn SA; Yeomans JS
Eur J Neurosci; 2013 Sep; 38(5):2774-85. PubMed ID: 23773170
[TBL] [Abstract][Full Text] [Related]
5. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
[TBL] [Abstract][Full Text] [Related]
6. Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice.
Schmidt LS; Miller AD; Lester DB; Bay-Richter C; Schülein C; Frikke-Schmidt H; Wess J; Blaha CD; Woldbye DP; Fink-Jensen A; Wortwein G
Psychopharmacology (Berl); 2010 Jan; 207(4):547-58. PubMed ID: 19820917
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine-induced 50 kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis.
Thompson B; Leonard KC; Brudzynski SM
Behav Brain Res; 2006 Mar; 168(1):64-73. PubMed ID: 16343652
[TBL] [Abstract][Full Text] [Related]
8. Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach.
Xu M
Ann N Y Acad Sci; 1998 May; 844():27-39. PubMed ID: 9668662
[TBL] [Abstract][Full Text] [Related]
9. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.
Lähdesmäki J; Sallinen J; MacDonald E; Scheinin M
Neuropsychopharmacology; 2004 Jul; 29(7):1282-93. PubMed ID: 15039766
[TBL] [Abstract][Full Text] [Related]
10. M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation.
Yeomans J; Forster G; Blaha C
Life Sci; 2001 Apr; 68(22-23):2449-56. PubMed ID: 11392612
[TBL] [Abstract][Full Text] [Related]
11. 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.
Charron A; Hage CE; Servonnet A; Samaha AN
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2381-93. PubMed ID: 26508706
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology.
Yamada M; Basile AS; Fedorova I; Zhang W; Duttaroy A; Cui Y; Lamping KG; Faraci FM; Deng CX; Wess J
Life Sci; 2003 Dec; 74(2-3):345-53. PubMed ID: 14607263
[TBL] [Abstract][Full Text] [Related]
13. M5 muscarinic receptor knockout mice show reduced morphine-induced locomotion but increased locomotion after cholinergic antagonism in the ventral tegmental area.
Steidl S; Yeomans JS
J Pharmacol Exp Ther; 2009 Jan; 328(1):263-75. PubMed ID: 18849356
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor blockade in the rat medial prefrontal cortex reduces spontaneous and amphetamine-induced activity and does not affect prepulse inhibition.
Bast T; Pezze MA; Feldon J
Behav Pharmacol; 2002 Dec; 13(8):669-73. PubMed ID: 12478219
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
[TBL] [Abstract][Full Text] [Related]
16. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion.
Broersen LM; Feldon J; Weiner I
Neuroscience; 1999; 94(1):39-46. PubMed ID: 10613495
[TBL] [Abstract][Full Text] [Related]
17. The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
Cáceda R; Binder EB; Kinkead B; Nemeroff CB
Schizophr Res; 2012 Apr; 136(1-3):88-95. PubMed ID: 22104138
[TBL] [Abstract][Full Text] [Related]
18. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
Rünkorg K; Värv S; Matsui T; Kõks S; Vasar E
Neurosci Lett; 2006 Oct; 406(1-2):17-22. PubMed ID: 16916582
[TBL] [Abstract][Full Text] [Related]
19. Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice.
Mohr D; Pilz PK; Plappert CF; Fendt M
Neuroreport; 2007 Sep; 18(14):1493-7. PubMed ID: 17712281
[TBL] [Abstract][Full Text] [Related]
20. Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia.
De Luca V; Wang H; Squassina A; Wong GW; Yeomans J; Kennedy JL
Neuropsychobiology; 2004; 50(2):124-7. PubMed ID: 15292665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
